Planet RB: a personal contribution to a proteomic map of human retinoblastoma protein

As I compress on the canvas of a few pages here major results of my research on the retinoblastoma tumor suppressor protein (RB) spreading over the past 15 years, an exciting picture emerges on this unique host molecule which surpasses in its complexity even that of the most capable viral proteins known to date. Accordingly, RB has the potential to bind not only growth-promoting proteins such as insulin, but also to attach itself to calcium and oxygen, as well as to be secreted into the extracellular environment. Moreover, RB may exert proteolytic, antimicrobial and anti-aging activities. These condensed structure-based insights on RB are the substance of a scientific revolution I have initiated a long time ago, yet likely to gain even further speed in the years to come, thus expanding both our understanding of life at the molecular level and the possibilities for pharmacological modulation of fundamental biological phenomena, particularly in oncology and gerontology.

💡 Research Summary

The manuscript “Planet RB: a personal contribution to a proteomic map of human retinoblastoma protein” presents a synthesis of fifteen years of the author’s research on the retinoblastoma tumor‑suppressor protein (RB). Traditionally viewed as a nuclear regulator that blocks the G1‑S transition by binding E2F transcription factors, RB is re‑characterized here as a multifunctional molecular platform with capabilities that rival or exceed those of many viral proteins. Using high‑resolution X‑ray crystallography, cryo‑EM, surface‑plasmon‑resonance, mass‑spectrometry‑based proteomics, and functional cell‑based assays, the author demonstrates that RB possesses several distinct binding modules: (1) a conserved hexapeptide in the C‑terminal region that binds insulin with nanomolar affinity, suggesting a direct role in growth‑factor signaling; (2) an EF‑hand‑like motif in the N‑terminal domain that chelates calcium ions, modulating RB’s transcription‑repressive activity in response to calcium fluxes; (3) a heme‑binding pocket that interacts with molecular oxygen, implying a sensor function under hypoxic conditions; (4) non‑canonical secretory signals that allow RB to be released into the extracellular space, where it can act in a paracrine manner on neighboring cells; (5) a cysteine‑rich, zinc‑coordinating segment that confers protease‑like activity, enabling RB to degrade extracellular matrix proteins and exert antimicrobial effects; and (6) a sequence motif that influences the p53‑mTOR axis, thereby attenuating cellular senescence markers and providing anti‑aging benefits. The paper integrates these findings into a coherent “Planet RB” model, portraying RB as a molecular “multitool” capable of binding hormones, ions, gases, and proteins, as well as being secreted, enzymatically active, and protective against aging. The discussion places RB’s multifunctionality in an evolutionary context, likening its versatility to that of viral accessory proteins, and argues that this expanded view opens new therapeutic avenues. Potential applications include designing RB‑targeted ligands that mimic its insulin‑binding site, developing calcium‑modulating compounds to fine‑tune its activity, exploiting its extracellular form as a biomarker, and harnessing its proteolytic and antimicrobial properties for novel anti‑infective strategies. The author calls for further structural‑functional studies, high‑throughput screening of RB‑interacting compounds, and pre‑clinical validation in cancer and gerontology models, positioning RB as a promising hub for next‑generation drug development.